04/25/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
11:15 PM | Aldeyra Therapeutics (Filer)
| Form EFFECT | |
04/22/2024
3:11 PM | Aldeyra Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:13 PM | Aldeyra Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:18 PM | Aldeyra Therapeutics (Filer)
| Form ARS | |
04/08/2024
4:32 PM | Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:22 PM | Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Warren Buffett's "mystery stock" (Ad) WARNING: Read This Before the Next Fed Meeting
Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some |
03/28/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
7:01 PM | Aldeyra Therapeutics (Issuer)
Brady Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:04 PM | Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:07 PM | Aldeyra Therapeutics (Issuer)
Greenberg Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:11 PM | Aldeyra Therapeutics (Subject)
Greenberg Bruce (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
7:43 PM | Aldeyra Therapeutics (Subject)
Machatha Stephen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
6:12 PM | Aldeyra Therapeutics (Subject)
Brady Todd C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:48 PM | Aldeyra Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
3:40 PM | Aldeyra Therapeutics (Filer)
| Form S-8 POS | |
01/04/2024
6:00 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
6:05 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
6:16 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
3:43 PM | Aldeyra Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/01/2023
6:09 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
5:07 PM | Aldeyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
10/18/2023
4:15 PM | Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
7:00 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
2:22 PM | Aldeyra Therapeutics (Subject)
Knoll Capital Management, LLC (Filed by)
| Form SC 13G | |
09/11/2023
4:42 PM | Aldeyra Therapeutics (Issuer)
Brady Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:31 PM | Aldeyra Therapeutics (Issuer)
Phillips Gary M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
3:13 PM | Aldeyra Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:42 PM | Aldeyra Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:43 PM | Aldeyra Therapeutics (Issuer)
Phillips Gary M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:46 PM | Aldeyra Therapeutics (Issuer)
JOYCE MARTIN JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:30 PM | Aldeyra Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:32 PM | Aldeyra Therapeutics (Issuer)
DOUGLAS RICHARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:34 PM | Aldeyra Therapeutics (Issuer)
Bronstein Ben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:07 PM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
3:23 PM | Aldeyra Therapeutics (Issuer)
Bronstein Ben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:25 PM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
